• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西南部一家参考中心的 2019 冠状病毒病感染的临床特征和严重程度预测因素:一项横断面研究。

Clinical profile and severity predictors of coronavirus disease 19 infection in a reference center from southern Brazil: a cross-sectional study.

机构信息

Pontifícia Universidade Católica do Rio Grande do Sul, Hospital São Lucas, Pneumology Division - Porto Alegre (RS), Brazil.

Hospital Moinhos de Vento, Pneumology Division - Porto Alegre (RS), Brazil.

出版信息

Rev Assoc Med Bras (1992). 2023 Apr 14;69(4):e20221271. doi: 10.1590/1806-9282.20221271. eCollection 2023.

DOI:10.1590/1806-9282.20221271
PMID:37075446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10176631/
Abstract

OBJECTIVES

The coronavirus disease pandemic has become a major global health crisis since 2019. Recent data show the association of diabetes, hypertension, and obesity with poor related outcomes in coronavirus disease infection. This descriptive study aimed to identify the clinical and laboratory parameters in patients with acute respiratory syndrome and confirmed severe acute respiratory syndrome coronavirus 2 infection.

METHODS

In this cross-sectional study, we analyzed data of 409 patients admitted to a referral hospital in Rio Grande do Sul, Brazil, with coronavirus disease infection confirmed by reverse transcription polymerase chain reaction. Clinical, laboratory, and imaging data were collected retrospectively from electronic medical records using a template with the variables of interest.

RESULTS

The average age was 64 years (52-73), and the body mass index was 27 kg/m² (22.1-31.2). Hypertension, diabetes, and obesity were observed in 58, 33, and 32% of the patients, respectively. Patients admitted to an intensive care unit were older [66 years (53-74) vs. 59 years (42.2-71.7)], with significantly higher impairment on chest computed tomography [75% (50-75) vs. 50% (25-60)] and received higher doses of corticosteroid therapy [39.4 mg (14.3-70.3) vs. 6 mg (6-14.7)]. Hematological parameters were lower in critically ill patients, with greater differences observed on the fifth day of hospitalization [hemoglobin 11.5 g/dL (9.5-13.1) vs. 12.8 g/dL (11.5-14.2), platelets 235,000 μL (143,000-357,000) vs. 270,000 μL (192,000-377,000), and lymphocytes 900 μL (555-1,500) vs. 1,629 μL (1,141-2,329)]. C-reactive protein levels and kidney function were also worse in intensive care unit patients. The mortality rate was significantly higher in the intensive care unit compared to the basic care unit (62.8 vs. 12.2%).

CONCLUSION

Our findings suggest that metabolic and cardiovascular comorbidities, as well as abnormal hematological parameters, are common findings among patients with severe respiratory syndrome related to coronavirus disease.

摘要

目的

自 2019 年以来,冠状病毒病已成为全球主要的卫生健康危机。最近的数据表明,糖尿病、高血压和肥胖症与冠状病毒病感染的不良相关结局有关。本描述性研究旨在确定患有急性呼吸综合征并确诊严重急性呼吸综合征冠状病毒 2 感染的患者的临床和实验室参数。

方法

在这项横断面研究中,我们分析了巴西南里奥格兰德州一家转诊医院 409 名经逆转录聚合酶链反应确诊为冠状病毒病感染的患者的数据。使用带有感兴趣变量的模板,从电子病历中回顾性地收集临床、实验室和影像学数据。

结果

平均年龄为 64 岁(52-73 岁),体重指数为 27kg/m²(22.1-31.2)。高血压、糖尿病和肥胖症分别在 58%、33%和 32%的患者中观察到。入住重症监护病房的患者年龄更大[66 岁(53-74 岁)比 59 岁(42.2-71.7 岁)],胸部计算机断层扫描(CT)损伤显著更高[75%(50-75)比 50%(25-60)],并接受更高剂量的皮质类固醇治疗[39.4mg(14.3-70.3)比 6mg(6-14.7)]。重症患者的血液学参数较低,住院第 5 天差异更大[血红蛋白 11.5g/dL(9.5-13.1)比 12.8g/dL(11.5-14.2),血小板 235,000μL(143,000-357,000)比 270,000μL(192,000-377,000),淋巴细胞 900μL(555-1500)比 1629μL(1141-2329)]。重症监护病房患者的 C 反应蛋白水平和肾功能也更差。与基础护理病房相比,重症监护病房的死亡率明显更高(62.8%比 12.2%)。

结论

我们的研究结果表明,代谢和心血管合并症以及异常的血液学参数是与冠状病毒病相关的严重呼吸综合征患者的常见表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c64/10176631/c3ef56427658/1806-9282-ramb-69-04-e20221271-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c64/10176631/c3ef56427658/1806-9282-ramb-69-04-e20221271-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c64/10176631/c3ef56427658/1806-9282-ramb-69-04-e20221271-gf01.jpg

相似文献

1
Clinical profile and severity predictors of coronavirus disease 19 infection in a reference center from southern Brazil: a cross-sectional study.巴西南部一家参考中心的 2019 冠状病毒病感染的临床特征和严重程度预测因素:一项横断面研究。
Rev Assoc Med Bras (1992). 2023 Apr 14;69(4):e20221271. doi: 10.1590/1806-9282.20221271. eCollection 2023.
2
Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.墨西哥东南部地区与 SARS-CoV-2 感染严重程度相关的合并症和实验室参数:一项横断面研究。
F1000Res. 2022 Jan 6;11:10. doi: 10.12688/f1000research.74023.2. eCollection 2022.
3
Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.患有严重或危急 2019 冠状病毒病的孕妇与未怀孕的匹配对照相比,复合发病率增加。
Am J Obstet Gynecol. 2021 May;224(5):510.e1-510.e12. doi: 10.1016/j.ajog.2020.11.022. Epub 2020 Nov 20.
4
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
5
Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.迪拜因 COVID-19 住院治疗的糖尿病患者的临床特征和结局:单中心横断面研究。
JMIR Public Health Surveill. 2020 Dec 7;6(4):e22471. doi: 10.2196/22471.
6
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.墨西哥门诊和住院患者严重急性呼吸综合征冠状病毒 2 感染后生存的决定因素。
Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
9
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中,与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
10
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy.维生素 D 与 COVID-19 严重程度和相关死亡率:意大利的一项前瞻性研究。
BMC Infect Dis. 2021 Jun 14;21(1):566. doi: 10.1186/s12879-021-06281-7.

引用本文的文献

1
Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review.肥胖作为 SARS-CoV-2 感染者并发症和死亡的风险因素:系统综述。
Nutrients. 2024 Feb 16;16(4):543. doi: 10.3390/nu16040543.
2
Predictors of mortality in hospitalised patients with COVID-19: a 1-year case-control study.COVID-19 住院患者死亡的预测因素:一项为期 1 年的病例对照研究。
BMJ Open. 2024 Feb 14;14(2):e072784. doi: 10.1136/bmjopen-2023-072784.

本文引用的文献

1
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies.糖尿病、高血压、体重指数、吸烟与 COVID-19 相关死亡率:观察性研究的系统评价和荟萃分析。
BMJ Open. 2021 Oct 25;11(10):e052777. doi: 10.1136/bmjopen-2021-052777.
2
Comparison of neutrophil lymphocyte ratio, platelet lymphocyte ratio, and mean platelet volume and PCR test in COVID-19 patients.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值和血小板平均体积与 PCR 检测在 COVID-19 患者中的比较。
Rev Assoc Med Bras (1992). 2021 Jul 9;67Suppl 1(Suppl 1):40-45. doi: 10.1590/1806-9282.67.Suppl1.20200630. eCollection 2021.
3
Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes.
COVID-19时代的地塞米松:是友是敌?一篇关于地塞米松的作用及其在糖尿病患者中不当使用潜在风险的文章。
Diabetol Metab Syndr. 2020 Sep 7;12:80. doi: 10.1186/s13098-020-00583-7. eCollection 2020.
4
Pros and cons of corticosteroid therapy for COVID-19 patients.COVID-19 患者使用皮质类固醇治疗的利弊。
Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.
5
Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).肥胖症和糖尿病是导致 2019 年冠状病毒病(COVID-19)重症的高危因素。
Diabetes Metab Res Rev. 2021 Feb;37(2):e3377. doi: 10.1002/dmrr.3377. Epub 2020 Jul 20.
6
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?新型冠状病毒肺炎、高血压和心血管疾病:我们是否应该改变治疗方法?
Pharmacol Res. 2020 Aug;158:104906. doi: 10.1016/j.phrs.2020.104906. Epub 2020 May 13.
7
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
8
Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).血小板功能和活性作为与 2019 年冠状病毒病(COVID-19)相关的潜在血液学参数。
Platelets. 2020 Jul 3;31(5):627-632. doi: 10.1080/09537104.2020.1762852. Epub 2020 May 13.
9
Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics).新型冠状病毒病(COVID-19):大流行(流行病学、发病机制及潜在治疗方法)
New Microbes New Infect. 2020 Apr 14;35:100679. doi: 10.1016/j.nmni.2020.100679. eCollection 2020 May.
10
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病(COVID-19)严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常:荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.